Related Experiment Video
Updated: Apr 6, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
New advances in genitourinary cancer: evidence gathered in 2014
C Suárez1, J Puente2, E Gallardo3
1Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Abstract:
This review provides updated information published in 2014 regarding advances and major achievements in genitourinary cancer. Sections include the best in prostate cancer, renal cancer, bladder cancer, and germ cell tumors. In the field of prostate cancer, data related to treatment approach of hormone-sensitive disease, castrate-resistant prostate cancer, mechanisms of resistance, new drugs, and molecular research are presented. In relation to renal cancer, relevant aspects in the treatment of advanced renal cell carcinoma, immunotherapy, and molecular research, including angiogenesis and von Hippel-Lindau gene, molecular biology of non-clear cell histologies, and epigenetics of clear renal cell cancer are described. New strategies in the management of muscle-invasive localized bladder cancer and metastatic disease are reported as well as salient findings of biomolecular research in urothelial cancer. Some approaches intended to improve outcomes in poor prognosis patients with metastatic germ cell cancer are also reported. Results of clinical trials in these areas are discussed.
Insights
This 2014 review highlights key advances in genitourinary cancers, including prostate, renal, and bladder cancers, and germ cell tumors. It covers new treatments, molecular research, and clinical trial outcomes for improved patient care.
Area of Science:
- Oncology
- Urology
- Genitourinary Cancer Research
Background:
- Genitourinary cancers represent a significant global health burden.
- Continuous research is vital for improving treatment strategies and patient outcomes.
Purpose of the Study:
- To review significant advancements in genitourinary cancer research published in 2014.
- To consolidate key findings in prostate, renal, bladder, and germ cell tumors.
Main Methods:
- Literature review of scientific publications from 2014.
- Synthesis of data on treatment approaches, molecular research, and clinical trials.
Main Results:
- Updates on hormone-sensitive and castrate-resistant prostate cancer treatments, including new drugs and resistance mechanisms.
- Advances in advanced renal cell carcinoma treatment, immunotherapy, and molecular research (angiogenesis, VHL gene, epigenetics).
- New strategies for muscle-invasive bladder cancer and metastatic disease, alongside urothelial cancer biomolecular findings and metastatic germ cell cancer outcomes.
Conclusions:
- Significant progress was made in 2014 across various genitourinary cancers.
- Emerging molecular research and novel therapeutic strategies offer promise for improved patient management.
More Related Videos
Related Concept Videos
Nursing Assessment of the Genitourinary System I: Health History
Targeted Cancer Therapies
There are several types of targeted therapies against...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Urinary Tract Calculi III: Medical Management

